OmniAb licenses an antibody discovery platform to drug developers and academic institutions. It last closed at $4.66 on Nov 20, down 7.36% on the day. The next earnings report for OABI is expected around Wed, Mar 3, 2027, after the close. For the quarter ended Sep 2026, OABI reported EPS of -$0.12 on revenue of $4.0M, with revenue up 78.3% from a year ago. Over its last 8 reports the stock moved an average of 12.3% the session after earnings. Over the last 12 months OABI insiders bought $0 of stock on the open market and sold $283K, according to SEC Form 4 filings.
AI Auto Pilots
Is OABI in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold OABI.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on OABIStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
OABI · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 8% below its 20 day and 4% below its 50 day average. It is 37% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 43). The nearest support is the swing low (Sep 28) at $4.55, and the nearest resistance the Pivot at $4.77.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 7.1%/day
Key levels
$5.4552 week high+17.0%
$5.0320 day average+7.9%
$4.94Pivot R1+6.0%
$4.93Swing high (Aug 26)+5.8%
$4.8250 day average+3.4%
$4.77Pivot+2.4%
$4.66Last close
$4.55Swing low (Sep 28)−2.4%
$4.50Pivot S1−3.4%
$3.97100 day average−14.8%
$2.94200 day average−36.9%
$1.3552 week low−71.0%
Indicators
RSI (14)
42.76
Middle of its range
Neutral
MACD
0.04
Below its signal line
Bearish
Stochastic
38.0
Middle of its range
Neutral
ADX (14)
14.0
No clear trend
Williams %R
-94.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-111.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−7.4%
Change over 10 sessions
Bearish
ATR (14)
$0.33
Typical daily range, 7.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
Turning up, nearing overbought
Short trendBullish
Long trendNeutral
MomentumStrong
StretchNear overbought
VolatilityHigh, 12.4%/day
Key levels
$5.4552 week high+17.0%
$5.0320 day average+7.9%
$4.94Pivot R1+6.0%
$4.93Swing high (Aug 26)+5.8%
$4.8250 day average+3.4%
$4.77Pivot+2.4%
$4.66Last close
$4.55Swing low (Sep 28)−2.4%
$4.50Pivot S1−3.4%
$3.97100 day average−14.8%
$2.94200 day average−36.9%
$1.3552 week low−71.0%
Indicators
RSI (14)
64.40
Strong, overbought above 70
Neutral
MACD
0.68
Above its signal line
Bullish
Stochastic
73.7
Middle of its range
Neutral
ADX (14)
43.0
Strong uptrend
Williams %R
-45.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
60.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+14.5%
Change over 10 sessions
Bullish
ATR (14)
$0.58
Typical daily range, 12.4% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for OABI
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how OABI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow OABI usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for OABIHow many large options trades hit OABI, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in OABI in the last 90 days.
From SEC Form 4 filings by OABI's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OABI is in one of them and how their past OABI trades turned out.
OmniAb is a discovery research company based in Emeryville, California. It licenses its antibody discovery technology to pharmaceutical and biotech companies and academic institutions. The platform uses genetically engineered rats, mice and chickens whose immune systems produce fully human antibody candidates, which are then screened to find those suited to a partner's drug development. Customers use the resulting antibodies in their own therapy programs.